Flying Through FDA: Test Runs For Pilot 1

FDA's Pilot 1 rolling review process has led to accelerated approvals for cutting edge therapies. In addition to smaller biotechs, some of the largest pharmaceutical companies in the world are using it - and having success. FDA's top drug reviewer tells you how to maximize the value of the temporary program.

By Ramsey Baghdadi

Eyetech Pharmaceuticals Inc. is hardly winning popularity contests right now. Investors expect its flagship product--the breakthrough ophthalmic medicine pegaptanib...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from In Vivo Archive

More from In Vivo